Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01840163 · ClinicalTrials.gov registry record · NA
A Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 537
- Enrollment target
NCT01840163 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 537 participants.
The verdict
NCT01840163, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 537 participants
- Enrollment target
Study Summary
This study examines the impact of an online decision tool for patients with early stage invasive breast cancer. The study is a randomized controlled trial (RCT) of 444 newly diagnosed patients, recruited from multiple surgical practices in two SEER catchment areas. Participants will be randomized to receive either a basic version of a decision tool (similar to existing website with breast cancer information) or an enhanced version (featuring a knowledge building component, a values clarification exercise, and a patient activation module). Our hypothesis is that patients who use the enhanced version of the tool will have greater knowledge of their test and treatment options, have a higher rate of high quality (i.e., informed, preference-concordant) decisions, and report more positive appraisal of the decision-making process.
Interventions
- OTHER Static version of CanSORT tool
- OTHER CanSORT Online Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 537 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01840163
The ClinicalTrials.gov registry entry for NCT01840163 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 537 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Static version of CanSORT tool is the first listed.
NCT01840163 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01840163 about?
NCT01840163 is a clinical study titled "A Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool". This study examines the impact of an online decision tool for patients with early stage invasive breast cancer. The study is a randomized controlled trial (RCT) of 444 newly diagnosed patients, recruited from multiple surgical practices in two SEER catchment areas. Participants will be randomized to...
What is the current status of trial NCT01840163?
This trial is currently completed. It is a NA study. The enrollment target is 537 participants. The study started on 2014-02. Estimated completion is 2017-09-01.
What interventions are being tested in trial NCT01840163?
The interventions under investigation include: Static version of CanSORT tool (OTHER), CanSORT Online Tool (OTHER).
Who is sponsoring clinical trial NCT01840163?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.